CH415662A - Verfahren zur Herstellung eines Arzneimittels mit die Coronargefässe erweiternder Wirkung - Google Patents

Verfahren zur Herstellung eines Arzneimittels mit die Coronargefässe erweiternder Wirkung

Info

Publication number
CH415662A
CH415662A CH478863A CH478863A CH415662A CH 415662 A CH415662 A CH 415662A CH 478863 A CH478863 A CH 478863A CH 478863 A CH478863 A CH 478863A CH 415662 A CH415662 A CH 415662A
Authority
CH
Switzerland
Prior art keywords
expanding
drug
production
effect
coronary vessels
Prior art date
Application number
CH478863A
Other languages
German (de)
English (en)
Inventor
Carlsson Sven
Original Assignee
Recip Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DENDAT1170417D priority Critical patent/DE1170417C2/de
Priority claimed from GB3832460A external-priority patent/GB923942A/en
Application filed by Recip Ab filed Critical Recip Ab
Publication of CH415662A publication Critical patent/CH415662A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CH478863A 1960-11-08 1963-04-17 Verfahren zur Herstellung eines Arzneimittels mit die Coronargefässe erweiternder Wirkung CH415662A (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DENDAT1170417D DE1170417C2 (de) 1963-04-17 Verfahren zur herstellung eines diphenyl-butylamins mit die coronargefaesse erweiternder wirkung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3832460A GB923942A (en) 1960-11-08 1960-11-08 New compounds, processes for preparing them and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
CH415662A true CH415662A (de) 1966-06-30

Family

ID=10402729

Family Applications (1)

Application Number Title Priority Date Filing Date
CH478863A CH415662A (de) 1960-11-08 1963-04-17 Verfahren zur Herstellung eines Arzneimittels mit die Coronargefässe erweiternder Wirkung

Country Status (5)

Country Link
US (1) US3371014A (OSRAM)
CH (1) CH415662A (OSRAM)
DE (1) DE1170417B (OSRAM)
FR (1) FR2636M (OSRAM)
SE (1) SE300218B (OSRAM)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5492933A (en) * 1993-10-08 1996-02-20 Sepracor, Inc. Methods and compositions for treating urinary incontinence and other disorders using optically pure R-terodiline and hydroxylated derivatives thereof
SE0103668D0 (sv) * 2001-11-02 2001-11-02 Astrazeneca Ab Method for the treatment of overactive blader
ATE502635T1 (de) 2002-08-19 2011-04-15 Pfizer Kombinationstherapie gegen hyperproliferative erkrankungen
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
EP2351569B1 (en) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
WO2007050783A2 (en) 2005-10-26 2007-05-03 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
DE102007039744A1 (de) * 2007-04-18 2008-10-23 Repa Boltersdorf Gmbh Pulper zum Recyceln eines Gemenges
US8883844B2 (en) 2010-09-24 2014-11-11 Nitrogenix Inc. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
JP2016516804A (ja) 2013-04-17 2016-06-09 ファイザー・インク 心血管疾患を治療するためのｎ−ピペリジン−３−イルベンズアミド誘導体
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
BR112021013807A2 (pt) 2019-01-18 2021-11-30 Astrazeneca Ab Inibidores de pcsk9 e seus métodos de uso

Also Published As

Publication number Publication date
SE300218B (OSRAM) 1968-04-22
FR2636M (fr) 1964-07-06
US3371014A (en) 1968-02-27
DE1170417B (de) 1964-05-21

Similar Documents

Publication Publication Date Title
CH423790A (de) Verfahren zur Herstellung eines Benzimidazols
CH433304A (de) Verfahren zur Herstellung eines Liponsäurederivates
AT290274B (de) Verfahren zur Herstellung eines Margarinefettes
CH444810A (de) Verfahren zur Herstellung eines lederartigen Werkstoffes
CH415662A (de) Verfahren zur Herstellung eines Arzneimittels mit die Coronargefässe erweiternder Wirkung
AT290857B (de) Verfahren zur Herstellung eines Schichtstoffes
AT270874B (de) Verfahren zur Herstellung eines Zahnpflegemittels
AT314300B (de) Verfahren zur Herstellung eines rohrförmigen Gebildes
AT290960B (de) Verfahren zur Herstellung eines plastischen Brotaufstrichs
AT308666B (de) Verfahren zur Herstellung eines Hefevorteiges
CH423019A (de) Verfahren zur Herstellung eines umhüllten Supraleiters
CH479506A (de) Verfahren zur Herstellung eines Undecatriens
CH491886A (de) Verfahren zur Herstellung eines Pregnadiens
CH465205A (de) Verfahren zur Herstellung von pigmentierten Kunststoffwaren
CH440352A (de) Verfahren zur Herstellung eines feinkörnigen Baustahls
CH387000A (de) Verfahren zur Herstellung eines sauerstoffabgebenden Produktes
CH513495A (de) Verfahren zur Herstellung eines rohrförmigen Gebildes
CH379180A (de) Verfahren zur Herstellung eines Reissverschlusses
AT311565B (de) Verfahren zur Herstellung eines neuen 6α-Methyl-19-nor-progesterons
AT231203B (de) Verfahren zur Herstellung eines Schmuckgegenstandes
AT257180B (de) Verfahren zur Herstellung eines Übergangsstückes
AT303222B (de) Verfahren zur Herstellung eines Kunststoffüberzuges
AT278994B (de) Verfahren zur Herstellung eines Überzugsmittels
CH450999A (de) Verfahren zur Herstellung eines titan-keramischen Filmes
AT241029B (de) Verfahren zur Herstellung eines Desinfektionsmittels